Primary |
Hypertension |
56.7% |
Product Used For Unknown Indication |
10.0% |
Mineral Supplementation |
6.7% |
Blood Pressure |
4.2% |
Blood Pressure Increased |
3.3% |
Peripheral Arterial Occlusive Disease |
3.3% |
Asthma |
1.7% |
Colitis Ulcerative |
1.7% |
Diabetes Mellitus |
1.7% |
Dyslipidaemia |
1.7% |
Thyroid Disorder |
1.7% |
Angina Pectoris |
0.8% |
Blood Glucose Abnormal |
0.8% |
Blood Pressure Abnormal |
0.8% |
Essential Hypertension |
0.8% |
Glomerulonephritis Membranous |
0.8% |
Hepatic Encephalopathy |
0.8% |
Neuralgia |
0.8% |
Portal Hypertension |
0.8% |
Prophylaxis |
0.8% |
|
Product Substitution Issue |
19.2% |
Headache |
9.6% |
Drug Ineffective |
7.7% |
Blood Pressure Increased |
5.8% |
Hyperhidrosis |
5.8% |
Joint Swelling |
5.8% |
Blood Pressure Inadequately Controlled |
3.8% |
Hyperkalaemia |
3.8% |
Loss Of Consciousness |
3.8% |
Medication Residue |
3.8% |
Oedema Peripheral |
3.8% |
Palpitations |
3.8% |
Product Quality Issue |
3.8% |
Product Taste Abnormal |
3.8% |
Tinnitus |
3.8% |
Tongue Disorder |
3.8% |
Alopecia |
1.9% |
Angioedema |
1.9% |
Angle Closure Glaucoma |
1.9% |
Asthenia |
1.9% |
|
Secondary |
Hypertension |
42.9% |
Product Used For Unknown Indication |
11.6% |
Pain |
10.0% |
Atrial Fibrillation |
3.6% |
Drug Use For Unknown Indication |
3.6% |
Cardiovascular Event Prophylaxis |
2.5% |
Hyperlipidaemia |
2.5% |
Type 2 Diabetes Mellitus |
2.5% |
Constipation |
2.2% |
Mineral Supplementation |
2.2% |
Coronary Artery Disease |
1.9% |
Essential Hypertension |
1.9% |
Asthma |
1.7% |
Diabetes Mellitus |
1.7% |
Glaucoma |
1.7% |
Polyuria |
1.7% |
Prostate Cancer |
1.7% |
Angina Pectoris |
1.4% |
Ill-defined Disorder |
1.4% |
Nausea |
1.4% |
|
Renal Failure Acute |
11.7% |
Aortic Dissection |
10.0% |
Tremor |
8.3% |
Hyponatraemia |
6.7% |
Loss Of Consciousness |
6.7% |
Myalgia |
6.7% |
Faecaloma |
5.0% |
Thrombocytopenia |
5.0% |
Blood Potassium Increased |
3.3% |
Blood Pressure Decreased |
3.3% |
Bradycardia |
3.3% |
Burnout Syndrome |
3.3% |
Cough |
3.3% |
Dizziness |
3.3% |
Hyperkalaemia |
3.3% |
Interstitial Lung Disease |
3.3% |
Left Ventricular Dysfunction |
3.3% |
Muscle Spasms |
3.3% |
Oedematous Pancreatitis |
3.3% |
Osmotic Demyelination Syndrome |
3.3% |
|
Concomitant |
Hypertension |
27.1% |
Product Used For Unknown Indication |
24.3% |
Drug Use For Unknown Indication |
7.3% |
Rheumatoid Arthritis |
6.0% |
Diabetes Mellitus |
5.2% |
Type 2 Diabetes Mellitus |
3.0% |
Atrial Fibrillation |
3.0% |
Pain |
3.0% |
Hepatitis C |
2.9% |
Prophylaxis |
2.7% |
Depression |
2.5% |
Osteoporosis |
2.2% |
Metastatic Renal Cell Carcinoma |
1.7% |
Blood Cholesterol Increased |
1.4% |
Blood Pressure |
1.4% |
Dyslipidaemia |
1.4% |
Hyperlipidaemia |
1.3% |
Colorectal Cancer |
1.2% |
Anxiety |
1.2% |
Insomnia |
1.2% |
|
Oedema Peripheral |
7.0% |
Vomiting |
7.0% |
Renal Failure Acute |
6.5% |
Drug Ineffective |
5.9% |
Nausea |
5.9% |
Pneumonia |
5.9% |
Pyrexia |
5.9% |
Bronchiectasis |
5.4% |
Diarrhoea |
4.9% |
Headache |
4.9% |
Weight Increased |
4.9% |
Blood Pressure Increased |
4.3% |
Renal Impairment |
4.3% |
Rhabdomyolysis |
4.3% |
Atrial Fibrillation |
3.8% |
Dyspnoea |
3.8% |
Pancytopenia |
3.8% |
Rash |
3.8% |
Renal Failure |
3.8% |
Somnolence |
3.8% |
|
Interacting |
Pain |
26.1% |
Hypertension |
17.4% |
Ascites |
8.7% |
Atrial Fibrillation |
8.7% |
Hyperlipidaemia |
6.5% |
Essential Hypertension |
4.3% |
Varices Oesophageal |
4.3% |
Anxiety |
2.2% |
Arrhythmia |
2.2% |
Benign Prostatic Hyperplasia |
2.2% |
Coronary Artery Disease |
2.2% |
Epilepsy |
2.2% |
Mental Impairment |
2.2% |
Myocardial Ischaemia |
2.2% |
Nausea |
2.2% |
Prophylaxis |
2.2% |
Prophylaxis Against Gastrointestinal Ulcer |
2.2% |
Type 2 Diabetes Mellitus |
2.2% |
|
Faecaloma |
30.0% |
Drug Interaction |
20.0% |
Hepatic Encephalopathy |
20.0% |
Personality Change |
10.0% |
Somnolence |
10.0% |
Tremor |
10.0% |
|